Compare Sana Biotechnology Inc (SANA) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs GeneDx Holdings Corp — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: GeneDx Holdings Corp is far larger — about 2.1× Sana Biotechnology Inc's market cap. Which is the better fit depends on your goals.
| SANA | WGS | |
|---|---|---|
Market Cap | $873.84M | $1.80B |
Sector | Health | Technology |
52-Week High | $5.92 | $167.51 |
52-Week Low | $2.68 | $34.51 |
Enterprise Value | $848.03M | $1.80B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
